Ralliant Corporation $RAL Shares Sold by DNB Asset Management AS

DNB Asset Management AS reduced its stake in shares of Ralliant Corporation (NYSE:RAL) by 57.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,074 shares of the company’s stock after selling 19,098 shares during the period. DNB Asset Management AS’s holdings in Ralliant were worth $615,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Manchester Capital Management LLC purchased a new position in Ralliant during the second quarter worth approximately $29,000. Westfuller Advisors LLC acquired a new stake in shares of Ralliant during the 3rd quarter worth $26,000. UMB Bank n.a. acquired a new stake in shares of Ralliant during the 3rd quarter worth $29,000. Webster Bank N. A. purchased a new position in shares of Ralliant in the 3rd quarter worth $31,000. Finally, SouthState Corp acquired a new position in Ralliant in the second quarter valued at $35,000.

Insiders Place Their Bets

In other Ralliant news, Director Anelise Angelino Sacks bought 2,000 shares of the business’s stock in a transaction on Monday, February 9th. The shares were bought at an average cost of $41.25 per share, with a total value of $82,500.00. Following the transaction, the director directly owned 5,403 shares in the company, valued at approximately $222,873.75. This trade represents a 58.77% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Kate Mitchell bought 2,350 shares of Ralliant stock in a transaction dated Tuesday, February 10th. The shares were acquired at an average price of $42.48 per share, with a total value of $99,828.00. Following the completion of the purchase, the director owned 8,411 shares in the company, valued at approximately $357,299.28. The trade was a 38.77% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders acquired a total of 8,145 shares of company stock valued at $332,233 in the last three months.

Ralliant Stock Up 2.7%

NYSE RAL opened at $47.01 on Thursday. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.38. Ralliant Corporation has a fifty-two week low of $37.27 and a fifty-two week high of $57.02. The business has a 50 day moving average price of $49.18 and a two-hundred day moving average price of $46.63. The stock has a market cap of $5.25 billion and a PE ratio of 23.98.

Ralliant (NYSE:RAL) last posted its earnings results on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. The firm had revenue of $554.60 million for the quarter, compared to analyst estimates of $543.04 million. Ralliant’s quarterly revenue was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 23rd. Stockholders of record on Monday, March 9th will be paid a dividend of $0.05 per share. The ex-dividend date is Monday, March 9th. This represents a $0.20 annualized dividend and a dividend yield of 0.4%. Ralliant’s dividend payout ratio (DPR) is currently 10.20%.

Analyst Upgrades and Downgrades

Several brokerages have commented on RAL. Morgan Stanley restated an “overweight” rating and set a $45.00 price target on shares of Ralliant in a research note on Friday, February 6th. Oppenheimer decreased their target price on Ralliant from $60.00 to $50.00 and set an “outperform” rating for the company in a report on Friday, February 6th. Weiss Ratings lowered shares of Ralliant from a “hold (c)” rating to a “sell (d)” rating in a report on Thursday, February 5th. Zacks Research downgraded shares of Ralliant from a “hold” rating to a “strong sell” rating in a research note on Monday, February 9th. Finally, Vertical Research raised shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price objective for the company in a research report on Friday, February 6th. Seven research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $50.50.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.